Skip to main content

Event summary produced by The Globe and Mail Events team. The Globe’s editorial department was not involved.

On May 5, The Globe and Mail hosted Nuclear Medicine: What does the future hold for Canada? This webcast explored new approaches to diagnosing, treating and managing illnesses such as cancer, heart disease and neurological disorders with nuclear medicine.

Maia Ingram, program manager of isotopes and business development at Bruce Power; Kathryn Hayashi, president and CEO at TRIUMF Innovations; Karin Stephenson, director of research platforms at McMaster University; and Dr. Sten Myrehaug, a radiation oncologist and clinician investigator for the Odette Cancer Centre at the Sunnybrook Health Sciences Centre, joined Globe and Mail health reporter and columnist, André Picard, for a discussion on what innovations and discoveries hold the most promise for patient care and outcomes.

View the full 60-minute event below.

The Globe and Mail presented the event with sponsor support from Bruce Power. For more information on upcoming Globe Events, visit our events hub at